AUSTIN, TX--(Marketwired - Apr 2, 2013) - Apollo Endosurgery, Inc., a company focused on the development of devices that enable a new generation of endoscopic surgical procedures, announced that its ...

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S ...

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...

Apollo Endosurgery posted a net loss of $8.8 million for the second quarter, despite growing worldwide sales of Overstitch, its endoscopic suturing system, by 40 percent. 1. In the U.S., the company ...

Here’s what you should know: 1. OverStitch Sx is an endoscopic suturing system that works with several single-channel flexible endoscopes. 2. The existing version of OverStitch was only compatible ...

Shares of Apollo Endosurgery Inc. rocketed 28% in premarket trade Tuesday, after the medical device company said the Food and Drug Administration cleared its new flexibile endoscopic suturing system, ...

During the 3-day virtual event, there were more than 30 different presentations featuring the use of the OverStitch Endoscopic Suturing System in a variety of endoscopic procedures. "We are very ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that ...